已收录 268921 条政策
 政策提纲
  • 暂无提纲
Phorbol Myristate Acetate Inhibits the Bradykinin-Induced L-Nitro-Arginine Insensitive Endothelium-Dependent Relaxation of Bovine Coronary Artery
[摘要] References(30)Cited-By(3)The effects of L-nitro-arginine (LNAG) and phorbol myristate acetate (PMA) were studied in bradykinin-induced relaxations in bovine coronary arteries. In the presence of indomethacin (10 μM), neither LNAG (100 μM) nor PMA (0.1 μM) inhibited the bradykinin-induced relaxations in coronary arterial rings contracted with prostaglandin F2α. However, simultaneous application of LNAG and PMA almost completely abolished the bradykinin-induced relaxation. In a sandwich-method, endothelium-intact coronary arteries (donor vessels) were treated with LNAG or with PMA for 30 min and then placed in close apposition to a denuded ring (assay vessel). Pretreatment of the donor vessels with LNAG, but not with PMA, almost completely abolished the bradykinin-induced relaxations in the assay vessel. In contrast, treatment of the assay vessel with PMA or with LNAG had no effect. These results suggest that bradykinin-induced endothelium-dependent relaxation of bovine coronary artery depends on both the release of nitric oxide and other endothelium-derived relaxing factor(s), which is an extremely labile substance(s), or a nondiffusible factor(s). PMA seems to inhibit the production and/or the release of the latter substance(s).
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 药理学
[关键词] Endothelium-dependent relaxation (bradykinin-induced);Coronary artery (bovine);L-Nitro-arginine;Nitric oxide;Phorbol myristate acetate [时效性] 
   浏览次数:19      统一登录查看全文      激活码登录查看全文